Previous Close | 311.66 |
1-Year Change | -11.58% |
6-Months Change | -6.77% |
3-Months Change | 3.71% |
Moving Avg (50d) | 306.23 |
Moving Avg (200d) | 334.22 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 23.1B |
Beta (3-Years) | 1.04 |
Revenue Growth (ttm) | 0.6% |
Net Profit Margin (ttm) | 19.11% |
Return On Assets (ttm) | 14.9% |
EPS (ttm) | 7.42 |
PE Ratio (ttm) | 42 |
Dividend Yield | 0.24% |
Asset Description: | West Pharmaceutical Services, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-18 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
322.922 | 332.419 | 338.751 | 348.249 | 364.078 | 379.908 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin... Wikipedia